Condition: Lymphedema · Gait Dysfunction · Physical Rehabilitation · Sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
This randomized controlled study aims to investigate the effects of virtual reality (VR)-assisted gait training, in addition to Complex Decongestive Therapy (CDT), on gait parameters, physical function, quality of life, and edema levels in patients with lower extremity lymphedema. Lymphedema is a progressive condition characterized by the accumulation of protein-rich fluid due to lymphatic drainage insufficiency, leading to chronic inflammation and fibrosis. It impairs gait patterns and reduces functional mobility. VR technologies, such as the RehaWalk system, provide interactive, personalized rehabilitation environments that enhance motor learning, motivation, and adherence to treatment. The study evaluates spatiotemporal gait parameters, three-zone foot analysis (heel, midfoot, forefoot), limb circumferences, ultrasound measurements (dermis, epidermis, subcutaneous fat thickness), and patient-reported outcomes. VR-based training offers a novel, engaging approach to improve physical rehabilitation outcomes in patients with lower limb lymphedema. No significant risks are expected in this study.
This description comes directly from the study's public registry record.
SEFA GÜMRÜK ASLAN · +903122911503 · sefagumrukk@gmail.com
sefa gümrük aslan, M.D. · +903122911503 · sefagumrukk@gmail.com
Always discuss trial participation with your own doctor first.
| Ankara Gaziler physical therapy and rehabilitationhospital | Ankara, Turkey (Türkiye) | Recruiting |
| Gaziler physical therapy and rehabilitation | Ankara, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07472543